Is NEXLIZET right for you? If your bad cholesterol levels are still too high, which can threaten your heart health, ask your doctor about NEXLIZET.

Sep 26, 2024 · This helps restore blood flow in adults with or at high risk of cardiovascular disease (CVD) who cannot take statins. The ezetimibe component reduces blood cholesterol by inhibiting the …

INDICATION NEXLIZET is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic …

3 days ago · The bempedoic acid component of NEXLIZET and NEXLETOL is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, myocardial infarction, stroke, or …

Overview Nexlizet is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic …

The most common adverse reactions in the cardiovascular outcomes trial for bempedoic acid, a component of NEXLIZET and NEXLETOL, at an incidence of ≥2% and 0.5% greater than placebo were …

3 days ago · Quiver AI Summary Esperion has announced the recognition of bempedoic acid as a key first-line therapy for lowering LDL cholesterol (LDL-C) in patients with peripheral artery disease (PAD) …

Jun 16, 2025 · What Is Nexlizet? Nexlizet is an FDA-approved oral non statin therapy specifically designed to help lower LDL cholesterol levels in adults with primary hyperlipidemia, including …

NEXLIZET® (NEX-lee-zet) (bempedoic acid and ezetimibe) tablets, for oral use What is NEXLIZET? NEXLIZET is a prescription medicine that contains 2 cholesterol-lowering medicines, bempedoic acid …

Dec 19, 2024 · Nexlizet is a cholesterol management medication available in tablet form, containing 180 mg of bempedoic acid and 10 mg of ezetimibe. It is primarily indicated for primary hyperlipidemia and …